No description available.

Made available in DSpace on 2015-05-14T12:59:54Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 1256477 bytes, checksum: f676b1f9aeaea49632e26bd31031dcf4 (MD5) Previous issue date: 2013-03-01 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Compounds derived from plants or animals have been instrumental in the discovery of anti-infective drugs, and now many synthetic antimicrobial drugs based on structural models of substances of natural origin. Several chemical compounds, natural and synthetic, have been reported as inhibitors of efflux pumps, acting as important additional tools in drug development co-formulated with appropriate antibiotics. In this study were evaluated seven N-Fenylmaleimides (NFM), gently assigned by Dr. Valdir Cechinel Filho (UNIVALI), obtained by organic synthesis. The values of the minimum inhibitory and bactericidal concentrations (MIC and MBC) of N-Fenylmaleimides (NFM), antibiotics and compounds NAB, by the broth microdilution method.Were determined the values of minimum inhibitory concentrations (MIC) of NFM, antibiotics and compounds NAB. In modulation of drug resistance, the MIC of the antibiotic compounds and NAB were determined in the presence and absence of subinibitory concentrations of NFM. Both studies were supplemented with analysis of in silico ADMET parameters. The derivatives 3,4-Cl-NFM, NFM-4-Cl and 4-CH3-NFM showed moderate antibacterial activity with MIC of up to 64 μg/mL in MSSA and MRSA strains. In the assay of modulation of drug resistance, 4-NO2-NFM reduced by up to four times the MIC of the antibiotic tetracycline and erythromycin. The 4-CH3 NFM showed the best results, with a reduction in MIC of the antibiotics tetracycline (up to 4-fold), erythromycin (16-fold), some representatives of fluoroquinolones (up to 4-fold) and compounds NAB (up to 4 times). By reducing the MIC of ethidium bromide, 4-CH3 NFM is considered in fact as a putative inhibitor of the efflux system in bacteria. In the analysis of molecular modeling, derivatives 3,4-Cl-NFM and 4-CH3-NFM, improved antibacterial and modulator compounds respectively, showed a profile with low toxic risk theoretical profile since they are promising to be used in drawing new derivatives more active and safer. The results presented here show that imidic derivatives may be used to potentiate the effect of antimicrobial agents to facilitate reintroduction of antibiotics currently ineffective for the clinical treatment of multiresistant infections. / Compostos derivados de vegetais ou animais têm sido cruciais na descoberta de drogas anti-infecciosas, e atualmente muitas drogas antimicrobianas sintéticas baseiam-se em modelos estruturais de substâncias de origem natural. Diversos compostos químicos, sintéticos e naturais, têm sido relatados como inibidores de bombas de efluxo, atuando como ferramentas adicionais importantes no desenvolvimento de fármacos co-formulados com os antibióticos apropriados. Neste trabalho foram avaliados sete N-Fenilmaleimidas (NFM), cedidas gentilmente pelo Prof. Dr. Valdir Cechinel Filho (UNIVALI), obtidas por síntese orgânica. Foram determinados os valores das concentrações inibitórias mínimas e bactericida (CIM e CBM) de N-Fenilmaleimidas, dos antibióticos e dos compostos NAB, pelo método da microdiluição em placa. Na atividade moduladora de drogas, as CIM dos antibióticos e compostos NAB foram determinadas na presença e ausência de concentrações subinibitórias das N-Fenilmaleimidas. Ambos os estudos foram complementados com análise in silico dos parâmetros ADMET. Os derivados 3,4-Cl-NFM, 4-Cl-NFM e 4-CH3-NFM mostraram atividade antibacteriana moderada, com CIM de até 64 μg/mL em cepas MSSA e MRSA. No ensaio da modulação da resistência a drogas, a 4-NO2-NFM reduziu em até 4 vezes a CIM dos antibióticos tetraciclina e eritromicina. A 4-CH3 NFM apresentou o melhor resultado, com redução da CIM dos antibióticos tetraciclina (até 4 vezes), eritromicina (até 16 vezes), alguns representantes das fluoroquinolonas (até 4 vezes) e compostos NAB (até 4 vezes). Ao reduzir a CIM do brometo de etídio, a 4-CH3 NFM é considerada de fato como inibidor putativo do sistema de efluxo em bactéria. Na análise da modelagem molecular, os derivados 3,4-Cl-NFM e 4-CH3 NFM, os quais apresentaram melhor atividade antibacteriana e moduladora da resistencia, respectivamente, mostraram um perfil com baixo risco tóxico teórico, resultado promissor para serem utilizados no desenho de novos derivados mais ativos e mais seguros. Os resultados aqui apresentaram mostram que derivados imídicos podem ser utilizados para potenciar o efeito de agentes antimicrobianos, de modo a facilitar a reintrodução de antibióticos atualmente ineficazes para o tratamento clínico de infecções multirresistentes.

A resistência aos antibióticos é um problema de saúde pública global com sérias consequências para o tratamento de várias infecções bacterianas. Os fatores de transcrição da família MarR têm sido descritos controlando resistência a antibióticos e vários outros processos em bactérias. Neste trabalho, estudamos mecanismos de resistência a antibióticos em Chromobacterium violaceum, uma bactéria Gram-negativa ambiental que pode atuar como um patógeno oportunista em humanos. A estratégia envolveu a varredura de um painel de treze linhagens mutantes de fatores de transcrição da família MarR de C. violaceum disponíveis, por testes de susceptibilidade a 24 antibióticos. Estes ensaios revelaram que apenas o mutante ?emrR apresentou resistência aumentada ao antibiótico ácido nalidíxico em relação à linhagem selvagem. Esta resistência aumentada do mutante ?emrR ao ácido nalidíxico foi revertida em uma linhagem complementada deste mutante, conforme verificado por ensaios de viabilidade, ensaios de difusão em disco e concentração inibitória mínima (MIC). O fenótipo de diminuída produção de violaceína deste mutante, observado em meio líquido, também foi complementado. Além disso, foi realizado o isolamento de mutantes espontâneos de C. violaceum resistentes a ácido nalidíxico com mutação pontual em emrR. Os ensaios de microarranjo de DNA mostraram que EmrR reprime algumas dezenas de genes, incluindo o operon emrCAB, o qual codifica a bomba de efluxo EmrCAB. Os ensaios de Northern blot confirmaram que o EmrR reprime o operon emrCAB, e que a expressão desta bomba é induzida por salicilato, mas não outros compostos, como ácido nalidíxico ou brometo de etídeo. Os ensaios de alteração de mobilidade eletroforética (EMSA) mostraram que a proteína EmrR purificada se liga diretamente às 8 regiões promotoras de emrR, emrCAB e vários outros genes do regulon EmrR, para exercer uma regulação negativa direta sobre esses genes. Um mutante nulo ?emrCAB foi obtido, mas a ausência desta bomba de efluxo não tornou C. violaceum mais susceptível ao ácido nalidíxico, sugerindo que ela é importante somente em condições nas quais é induzida. Estas condições indutoras talvez incluam estresse oxidativo, uma vez que enzimas antioxidantes são parte do regulon de EmrR e a proteína EmrR formou dímeros covalentes na presença de agentes oxidantes in vitro. Portanto, nossos dados revelam que mutações pontuais ou moléculas como salicilato abolem a atividade repressora do fator de transcrição EmrR sobre o operon emrCAB, levando a superexpressão da bomba de efluxo EmrCAB e aumentando a resistência ao ácido nalidíxico em C. violaceum. / Antibiotic resistance is a global public health problem with serious consequences for the treatment of various bacterial infections. MarR family transcription factors have been described controlling antibiotic resistance and several other processes in bacteria. In this work, we studied mechanisms of antibiotic resistance in Chromobacterium violaceum, an environmental Gramnegative bacterium that can act as a human opportunistic pathogen. The strategy involved a screening of an available collection of thirteen C. violaceum mutant strains of MarR family transcription factors, by susceptibility testing for 24 antibiotics. These assays revealed that only the ?emrR mutant showed increased resistance to the antibiotic nalidixic acid in relation to the wild-type strain. This increased resistance of the ?emrR mutant to nalidixic acid was reversed in a complemented strain of this mutant, as verified by viability, disk diffusion, and minimal inhibitory concentration (MIC) assays. The phenotype of decreased violacein production of this mutant, observed in a liquid medium, was also complemented. In addition, it was performed the isolation of spontaneous mutants of C. violaceum resistant to nalidixic acid with a point mutation in emrR. DNA microarray assays showed that EmrR represses a few dozen of genes, including the emrCAB operon, which encodes the EmrCAB efflux pump. Northern blot assays confirmed that EmrR represses the emrCAB operon and that the expression of this pump is induced by salicylate, but not other compounds, such as nalidixic acid or ethidium bromide. Electrophoretic mobility shift assays (EMSA) showed that the purified EmrR protein binds directly to the promoter regions of emrR, emrCAB and several other genes of the EmrR regulon, to exert a direct negative regulation of these genes. A ?emrCAB null mutant strain was obtained, but the absence of this efflux pump did not make C. violaceum more susceptible to nalidixic acid, suggesting that it is important only under conditions in which it is induced. These inducing conditions may include 10 oxidative stress since antioxidant enzymes are part of the EmrR regulon and the EmrR protein has formed covalent dimers in the presence of oxidizing agents in vitro. Therefore, our data reveal that point mutations or molecules such as salicylate abolish the repressive activity of the EmrR transcription factor on the emrCAB operon, causing overexpression of the EmrCAB efflux pump and increasing the resistance to nalidixic acid in C. violaceum.

Dans ce travail de thèse, l'efficacité de la voie intrapulmonaire et les paramètres biopharmaceutiques influençant la diffusion pulmonaire après nébulisation d'antibiotiques ont été évalués. La présence et l'impact de certaines pompes d'efflux dans un modèle in vitro de cellules primaires épithéliales pulmonaires de rat ont été testés. Trois fluoroquinolones et la colistine ont été utilisées comme molécules de référence. La combinaison des molécules testées a permis d'obtenir une vue d'ensemble des caractéristiques de diffusion intrapulmonaire des antibiotiques. L'étude in vivo avec les fluoroquinolones a démontré que les concentrations pulmonaires de ces molécules sont plus importantes que dans le plasma, probablement dû à la présence des transporteurs comme la glycoprotéine-P. La présence de ces transporteurs a été confirmée dans le modèle de cellules pulmonaires de rats. L'étude in vivo avec la colistine a montré qu'une lente diffusion pourrait conférer un avantage à la nébulisation par rapport à l'administration intraveineuse. En conclusion, l'administration par nébulisation des molécules, qui traversent les tissus lentement (colistine), pourrait être avantageuse, alors que pour d'autres, qui traversent vite la barrière (fluoroquinolones), la voie nébulisée pourrait ne pas présenter des avantages par rapport à la voie intraveineuse. De plus, les résultats ont démontré qu'une faible perméabilité à travers le poumon (colistine) pourrait donner un avantage à la nébulisation des antibiotiques, tandis qu'une affinité pour des transporteurs (fluoroquinolones) semble présenter un intérêt aussi bien dans le cadre d'une nébulisation que d'une administration intraveineuse. / The aim of this study was to investigate the efficiency of intrapulmonary administration and the biopharmaceutical parameters regulating the pulmonary diffusion following nebulization. We examined whether certain efflux pumps were present in an in vitro model of rat lung cells and whether these efflux pumps could be beneficial by increasing lung concentrations in vivo. Fluoroquinolones and colistin were the molecules used as reference. These different molecules allowed an overview of the intrapulmonary diffusion characteristics of antibiotics. The in vivo study with fluoroquinolones showed that their lung concentrations are higher than in plasma, probably due to glycoprotein-P. The presence of this efflux pump was confirmed in the model with rat lung cells. The in vivo study with colistin showed that a slow diffusion may confer an advantage for nebulization over intravenous administration. In conclusion, the nebulization molecules passing slowly (colistin) across the tissues may be advantageous, whereas for others, with a fast passage across the barrier (fluoroquinolones), the pulmonary route may not provide an advantage over the intravenous administration. Moreover, the results showed that a slow permeability across the lung (colistin) may confer an advantage for the antibiotic nebulization, while affinity by transporters (fluoroquinolones) is beneficial for both nebulization and intravenous administration.

La diffusion des entérobactéries multirésistantes aux antibiotiques (MDR) à l’échelle mondiale constitue une menace de santé publique majeure. Résistantes à au moins trois classes d’antibiotiques, les entérobactéries MDR entrainent des infections échappant aux traitements de première intention. La première partie de ce travail s’intéresse à l’épidémiologie moléculaire des souches d’entérobactéries MDR isolées dans les infections et les colonisations des patients hospitalisés en Languedoc-Roussillon, en France, et dans un pays où cette épidémiologie est encore peu connue, l’Algérie. Nous avons montré, dans notre région et au niveau national, que la résistance aux carbapénèmes était essentiellement liée à des modifications de la perméabilité membranaire (87,4% des entérobactéries résistantes, au niveau national). Dans la deuxième partie de ce travail, nous avons étudié les modulations de la perméabilité membranaire et de l’efflux chez Escherichia coli ST131, l’exemple-type d’un clone MDR. Nous avons montré que ce clone mondial présentait une remarquable adaptabilité à la pression antibiotique. Cette adaptabilité avait un impact significatif sur la virulence et le fitness de E. coli. Les capacités de formation de biofilm et la virulence chez Caenorhabditis elegans étaient augmentées chez les souches de phénotypes « efflux ». Inversement, les souches de phénotypes « imperméabilité » présentaient un faible potentiel de virulence, associé à une diminution significative de la formation de biofilm et de la mobilité par swimming. / The spread of multidrug-resistant (MDR) Enterobacteriaceae is a major public health threat worldwide. Resistant to at least three classes of antibiotics, MDR Enterobacteriaceae cause infections for which first-line treatments are inefficient. The first part of this work focused on the molecular epidemiology of MDR Enterobacteriaceae strains isolated in infections and colonizations of patients hospitalized in Languedoc-Roussillon, in France and in Algeria, a country where few data are currently available. We showed in our region and nationally, that resistance to carbapenems was mainly due to changes in membrane permeability (87.4% of resistant Enterobacteriaceae, nationally).In the second part of this work, we studied the modulation of membrane efflux and permeability in the quintessential example of an international MDR high-risk clone, Escherichia coli ST131. We showed that this global clone had a remarkable adaptability to antibiotic pressure. This adaptability had a significant impact on the virulence and the fitness of E. coli. The biofilm formation and virulence capacities in Caenorhabditis elegans model were increased in strains overexpressing an efflux system. Conversely, the strains with altered porins expression had a low potential virulence, associated with a significant reduction in biofilm formation and swimming mobility.

No description available.

<p>In the past few decades, invasive mycosis has become a growing threat to global health, afflicting millions of people and claiming the lives of more than 1.5 million patients every year. Moreover, the economic burden of mycotic infections has become increasingly exhausting especially with the recent increases in the number of the high-risk population, the immunocompromised individuals. In the USA, the cost incurred by mycotic infections was estimated to be of more than $7.2 billion only in 2017. Of particular concern, <i>Candida</i> species are the most common fungal pathogens that infect humans, resulting in considerable morbidities and mortality rates that often exceed 50%. Unfortunately, the antifungal drug discovery is currently unable to keep pace with the urgent demand for more effective therapeutic options. Further complicating the situation is the recent emergence of multidrug-resistant species such as <i>Candida</i> <i>auris</i>, triggering outbreaks of deadly Candidemia across the globe. Given the risks inherent to the traditional de-novo drug discovery, combinatorial therapeutics stands out as a promising tool to hamper drug resistance and extend the clinical utility of the existing drugs. In this study, we assembled and screened ~3147 FDA-approved drugs and clinical molecules against fluconazole-resistant <i>C. albicans</i> and <i>C. auris</i> isolates, for the aim of restoring the antifungal activity of azole antifungals against drug-resistant <i>Candida </i>species. The screen revealed five promising hits: pitavastatin (antihyperlipidemic), ospemifene (estrogen receptor modulator), sulfa antibacterial drugs, lopinavir (antiviral), and aprepitant (antiemetic).</p> <p>All identified hits demonstrated variable azole chemosensitizing activities depending on the tested <i>Candida</i> species and the azole drug. Pitavastatin displayed broad-spectrum synergistic interactions with both fluconazole and voriconazole against isolates of <i>C. albicans</i>, <i>C. glabrata</i>, and <i>C. auris</i>. Ospemifene was able to interact synergistically with itraconazole against multiple fungal isolates including <i>Candida</i>, <i>Cryptococcus</i>, and <i>Aspergillus</i> species. Sulfa drugs displayed potent synergistic activities with different azoles against <i>C. albicans</i>, however, a limited efficacy was observed against efflux-hyperactive isolates such as <i>C. auris</i>. On the other hand, both lopinavir and aprepitant exerted potent and broad-spectrum synergistic activities with itraconazole and were effective against multiple <i>Candida</i> species including <i>C. albicans</i>, <i>C. auris</i>, <i>C. glabrata</i>, <i>C. krusie</i>, <i>C. tropicalis</i>, and <i>C. parapsilosis</i>. Furthermore, using <i>Caenorhabditis elegans</i> as an infection model, all drug combinations significantly reduced the fungal burden in the infected nematodes and significantly prolonged their survival as compared to single-drug treatments. Multiple phenotypic and molecular assays indicted that the identified hit compounds use distinct mechanisms to enhance the antifungal activity of azole drugs. These mechanisms include efflux pump inhibition, interference with the folate biosynthesis and disturbance of iron homeostasis. Taken together, this study reveals novel and potent azole chemosensitizing agents effective against multiple azole-resistant isolates and opens the door for more investigations to assess their clinical potential in human medicine as promising antifungal adjuvants.</p>

Les espèces bactériennes opportunistes responsables d'infections nosocomiales chez l'Homme se rencontrent dans les environnements terrestres et aquatiques. Elles sont très souvent caractérisées par une résistance naturelle aux antibiotiques leur conférant un phénotype appelé Multi-Drug Resistant (MDR). L'efflux d'antibiotiques via des pompes, est un des mécanismes à l'origine de cette multi-résistance. Alors que le rôle de ces pompes chez des bactéries isolées en milieu clinique est connu, aucune donnée n'est disponible concernant leur rôle chez les bactéries associées avec d'autres organismes eucaryotes du sol tels que les amibes. Pourtant des données de la littérature indiquent que les amibes, jusqu'alors principalement connues pour leur rôle prédateur de bactéries sont susceptibles d'héberger des bactéries " résistantes " aux amibes (ARB). Parmi ces ARB, des pathogènes opportunistes ont été identifiés dont certains sont connus pour être porteurs de pompes à efflux. Les pompes à efflux de ces bactéries pourraient donc intervenir dans l'adaptation aux amibes du sol. Afin de vérifier cette hypothèse, nous avons, dans un premier temps, isolé et identifié la flore amibienne et les ARB de différents sols. Parmi les ARB identifiées, Stenotrophomonas maltophilia, Pseudomonas aeruginosa et Burkholderia cepacia sont caractérisées par des propriétés d'antibiorésistance contrastées et de virulence élevées. Des études d'interaction ont montré que S. maltophilia se multipliait dans des amibes axéniques et que des pompes à efflux Sme étaient surexprimées. Par ailleurs des molécules sécrétées par l'amibe stimulent la croissance bactérienne et des études préliminaires de profilage métabolique ont montré la présence de différents métabolites secondaires produits par l'amibe au cours de l'interaction avec S. maltophilia pouvant jouer un rôle dans l'expression des pompes à efflux / The opportunistic bacterial species, responsible for nosocomial infections in humans, occurs in terrestrial and aquatic environments. They are often characterized by natural resistance to antibiotics giving them a phenotype called Multi-Drug Resistant (MDR). The efflux of antibiotics via pumps, is one of the mechanisms behind this multi-resistance. While the role of these pumps in bacteria isolated from hospital is known, no data are available regarding their role in bacteria associated with other soil eukaryotic organisms such as amoebae. Nevertheless, data from the literature indicate that amoebae, mainly known to be predators of bacteria, are likely to harbour "amoeba resistant bacteria” (ARB). Among these ARB, opportunistic pathogens have been identified, some of which are known to be carriers of efflux pumps. The efflux pumps of these bacteria could thus interfere in the adaptation to soil amoebae. In order to verify this hypothesis, we first isolated and identified the amoebal population and the ARB of different soils. Among the identified ARB, Stenotrophomonas maltophilia, Pseudomonas aeruginosa and Burkholderia cepacia are characterized by high contrast antibiotic resistance and high virulence. Interaction studies showed that S. maltophilia could multiplied in axenic amoebae and Sme efflux pumps were overexpressed. Furthermore, molecules secreted by the amoeba stimulate bacterial growth and preliminary studies of metabolic profile have shown that production of various secondary metabolites by the amoeba during the interaction with S. maltophilia could play a role in the efflux pumps expression

Les pompes d'efflux sont des complexes macromoléculaires qui permettent l'efflux des antibiotiques à travers les deux membranes (interne et externe). Ces pompes, spécifiques des bactéries Gram négatif, constituent l'un des acteurs majeurs du phénomène de résistance aux antibiotiques, en contribuant ainsi à la résistance intrinsèque et acquise de ces bactéries à de nombreuses molécules utilisées en antibiothérapie. Chez P. aeruginosa, ces pompes appartiennent pour la plupart à la famille des transporteurs RND. Ce sont des complexes tripartites constitués d'un transporteur de la membrane interne (RND), d'un adaptateur périplasmique (MFP) et d'un canal de la membrane externe (OMF). Ces composants ont été caractérisés individuellement chez de nombreuses bactéries. Cependant, les mécanismes qui régissent l'assemblage et la dissociation de la pompe, essentiels pour son fonctionnement, demeurent mal compris. Nous nous sommes donc intéressés au cours de ce travail aux pompes à efflux de Pseudomonas aeruginosa. Nous avons notamment procédé à la caractérisation structurale du canal OprN de la pompe MexEF-OprN impliquée dans la résistance aux fluoroquinolones et à la caractérisation biophysique du transporteur RND MexY de la pompe MexXY-OprM, spécifique des aminoglycosides. Nous avons étudié en parallèle le mécanisme d'ouverture du canal OprM seul in vitro (aspects structuraux) et in vivo (aspects fonctionnels) au sein de la pompe assemblée. Nos résultats montrent que les OMFs de P. aeruginosa présentent des similitudes avec les OMFs d'autres bactéries Gram négatif, mais également des différences, notamment pour OprN et OprM au niveau de l'interaction avec leurs partenaires ou encore pour OprM concernant l'ouverture du canal. Nous avons par ailleurs participé à l'étude in vitro de l'assemblage et du transport à travers la pompe MexAB-OprM, reconstituée au sein de protéoliposomes, confirmant l'importance de l'acylation de la MFP dans la formation du complexe et montrant l'importance de la force proto-motrice dans l'assemblage de la pompe mais pas dans sa dissociation. En parallèle de l'étude des pompes à efflux, nous nous sommes intéressés à un autre système de résistance, impliqué dans la dégradation des antibiotiques. Nous avons donc réalisé, en collaboration avec le Pr Patrick Plésiat (laboratoire de Bactériologie de Besançon), la modélisation de mutants de la beta-lactamase AmpC de P. aeruginosa, permettant de lier les effets fonctionnels observés à des hypothèses de modifications conformationnelles. / Multidrug efflux systems are membrane transport proteins that are used to translocate a wide variety of drugs across the inner and the outer membranes of Gram-negative bacteria, leading to natural and acquired antimicrobial resistances.Most of the multidrug transporters of P. aeruginosa belong to the resistance-nodulation-cell division (RND) superfamily.They function as three-component assemblies made of an inner membrane transporter (RND), a periplasmic membrane fusion protein (MFP) and an outer membrane factor channel (OMF). Along with functional studies, many crystal structures of the individual components of the pump have been solved but the interactions underlying the complex assembly and the opening mechanism of the outer channel remain unclear. In this study, we investigated structural and functional insights of P. aeruginosa efflux pumps. We solved the crystal structure of the MexEF-OprN efflux pump outer membrane channel OprN mainly involved in fluoroquinolones resistance. Our new structure highlights the differences between P. aeruginosa and other Gram-negative bacteria OMFs that could explain their specific interaction with the cognate MFP partners. We also purified and characterized the inner membrane transporter MexY from the MexXY-OprM efflux pump, which is the major determinant of aminoglycosides resistance in P. aeruginosa. Besides, we solved the crystal structure of a mutatedform of the outer membrane channel OprM in order to understand its opening mechanism. We also investigated in vivo effect of the OprM mutants in antibiotics resistance by MIC measurements and tried to correlate with the observed structural modifications leading to the open state. Moreover, we set up a new in vitro test allowing the investigation of the assembly of the MexAB-OprM efflux pump. Our results showed the importance of MexA and its lipid anchor in promoting and stabilizing the complex assembly. In addition, as a side project with the group of Pr Plésiat (laboratoire de Bactériologie de Besançon), we built different structural models of AmpC mutants from overproducing clinical isolates,showing the possible conformational changes that lead to the resistance increase.

[Truncated abstract] Pseudomonas aeruginosa, an important opportunistic pathogen, is resistant to a wide array of functionally and structurally diverse antimicrobial agents including antibiotics, disinfectants and biocides. P. aeruginosa is more resistant than other Gram negative bacteria to tea tree oil (TTO), the essential oil steam distilled from the leaves of Melaleuca alternifolia and comprised of over 100 terpene hydrocarbon components and their oxygenated derivatives. TTO is an established topical antimicrobial agent, with antibacterial, antiviral and antifungal properties. Intrinsic antimicrobial resistance mechanisms in P. aeruginosa include the low permeability of the outer membrane and expression of multi-drug efflux pumps. A series of multi-drug efflux mutants from the resistance-nodulation-cell division family was obtained and their susceptibility to TTO and several components examined. This demonstrated that TTO and the components terpinen-4-ol, 1,8-cineole and a-terpineol were substrates of MexAB-OprM, using both pump deletion mutants and the pump inhibitor Phe-arg ß-naphthylamide dihydrochloride. In complementation studies, the addition of mexAB-oprM to deletion mutants restored susceptibility to these agents to that of the wild-type, confirming the role of MexAB-OprM in tolerance to TTO and these three components. ... An increase in susceptibility to ticarcillin and Timentin occurred in PAO1 following serial subculture in terpinen-4-ol. Susceptibility to ticarcillin has been associated with expression of the MexCD-OprJ system in P. aeruginosa. A library of transposon mutants was created to find additional mechanisms by which P. aeruginosa could tolerate TTO. The library yielded a total of 20 mutants that were more susceptible than parental strains to TTO and/or terpinen-4-ol. The insertion site of the transposon was identified in 14 mutants and, in four mutants, this was a gene related to flagellar biosynthesis. Flagella deficient mutants have previously demonstrated enhanced susceptibility to the membrane-disrupting surfactant sodium dodecyl sulfate and this echoes the increased susceptibility to TTO and terpinen-4-ol observed. Three non-sibling surA mutants were also identified. SurA is involved in the correct folding of outer membrane proteins, including porins, in Gram negative bacteria: surA mutants of Escherichia coli have phenotypes that are characteristic of a defective cell envelope, including an increased susceptibility to hydrophobic agents. The increase in susceptibility to hydrophobic TTO and terpinen-4-ol in the surA mutants is consistent with this and represents the first report linking SurA function to antimicrobial resistance in P. aeruginosa. In conclusion, several Mex efflux systems of P. aeruginosa including MexAB-OprM, MexCD-OprJ and MexEF-OprN, as well as the LPS core, outer membrane integrity and a functioning flagella biosynthetic pathway contribute to the tolerance of this organism to TTO and/or several components.